🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: DATScan

Found 0 matching trials

Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients' First Degree Relatives

N/A

Parkinson Disease is one of the most common neurodegenerative illnesses. Fi...

Status

Unknown

Location

Department of Nuclear Medicine, Tel Aviv Sourasky Medical Center

Start Date

2010-03

Trial ID

NCT01089270

[18F] LBT-999 PET Compared to [123I]-FP/CIT SPECT to Distinguish Between Parkinson's Diseases and Essential Tremor

PHASE3

Clinical study to demonstrate an at least equivalent performance of a new P...

Status

Completed

Location

Hôpital Avicenne

Start Date

2021-12-01

Trial ID

NCT04265209

Treatments Being Tested

SPECT PET

Phase 0 Evaluation of [18F]MNI-958 as a Potential PET Radioligand for Imaging Tau Protein in the Brain

EARLY_PHASE1

The overall goal of this imaging trial is to evaluate \[18F\]MNI-958, a tau...

Status

Completed

Location

Molecular NeuroImaging, LLC

Start Date

2016-11-29

Trial ID

NCT03058965

Treatments Being Tested

[18F]MNI-958 [18F]Florbetapir DaTscan

Parkinson's Disease Biomarker Program

N/A

The primary objective of this study is to obtain detailed clinical informat...

Status

Completed

Location

UT Southwestern Medical Center

Start Date

2012-11

Trial ID

NCT01767818

Evaluation of the Use of Machine Learning Techniques to Classify Neurodegenerative PARKinsonian Syndromes (Artificial Intelligence)

N/A

The diagnosis of Parkinson's disease (PD) relies mainly on clinical observa...

Status

Completed

Location

Nuclear medicine department CHRU de NANCY

Start Date

2021-12-20

Trial ID

NCT05080296

Validation of DaTscan for Detection of Parkinson Disease Related Disorders

N/A

This investigator initiated trial is designed to measure the accuracy of di...

Status

Unknown

Location

Medical College of Wisconsin

Start Date

2014-07

Trial ID

NCT02138682

Treatments Being Tested

l-123 Ioflupane

Quantitative Mapping of Substantia Nigra Iron in Parkinson's Disease (Stages I-IV, REM Sleep Behavior Disorder) and Controls

PHASE1

Prospective, single center study to determine whether the current R2\* iron...

Status

Completed

Location

Hospital for Special Surgery

Start Date

2018-08-14

Trial ID

NCT03675282

Treatments Being Tested

(11C)PE2I Ioflupane

The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech

N/A

The purpose of this study is to identify and distinguish two different type...

Status

Recruiting

Location

Mayo Clinic

Start Date

2017-08-01

Trial ID

NCT03313011

Treatments Being Tested

Testing protocol for the study

A Study to Evaluate the Safety, Biodistribution, Internal Radiation Dosimetry, and Effective Dose of DaTSCAN™ Ioflupane (123I) Injection in Chinese Healthy Volunteers.

PHASE1

This is a phase 1, single-centre, single-group, nonrandomized, noncomparati...

Status

Completed

Location

Rujin hospital, affiliated to Shanghai Jiaotong University, School of Medicine

Start Date

2021-05-13

Trial ID

NCT04564092

Treatments Being Tested

DaTSCAN™ Ioflupane (123I) Injection

Relationship Between Symptoms, Retinal Morphology, and the Nigrostriatal Dopamine System in Parkinson's Disease

N/A

The purpose of this study is to examine if a correlation exists between fin...

Status

Completed

Location

Thomas Jefferson University

Start Date

2015-12

Trial ID

NCT02443779

Previous Next